SPPI — Spectrum Pharmaceuticals Balance Sheet
0.000.00%
HealthcareSpeculativeSmall Cap
- $211.40m
- $184.11m
- $10.11m
Annual balance sheet for Spectrum Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 204 | 224 | 180 | 101 | 75.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 33.6 | 10 | 2.46 | 1.03 | 13.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 251 | 244 | 187 | 104 | 101 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.385 | 15.4 | 5.82 | 2.96 | 2.17 |
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 391 | 263 | 197 | 112 | 103 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 98.3 | 62 | 53.1 | 53.2 | 42.7 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 119 | 73 | 62.6 | 64 | 75.5 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 271 | 190 | 134 | 47.6 | 27.9 |
Total Liabilities & Shareholders' Equity | 391 | 263 | 197 | 112 | 103 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |